Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

These variables differed significantly between the two groups (P < 0.05) (Table 1).Clinical and biochemical characteristics of patients divided into the mild group and severe group by the AAC scoreVariablesAll patients (n = 90)Mild AAC group (n = 68)Severe AAC group (n = 22)P valuesAge, years63.43 ± 13.2061.25 ± 13.2970.18 ± 10.590.005Male (%)53 (58.89)43 (63.24)10 (45.45)0.212Dialysis vintage, months69.78 ± 48.3060.88 ± 43.4497.27 ± 53.070.002BMI, kg/m223.84 ± 3.7923.78 ± 3.8924.01 ± 3.560.806Current smoker (%)18 (20.00)15 (22.06)3 (13.64)0.544Coronary risk equivalents (%)49 (54.44)35 (51.47)14 (63.64)0.339Primary disease DKD (%)34 (37.78)30 (44.12)4 (18.18)0.042 CG (%)22 (24.44)13 (19.12)9 (40.91)0.049 HRD (%)13 (14.44)9 (13.24)4 (18.18)0.728 Other (%)21 (23.33)16 (23.53)5 (22.73)1.000Medication use (during QCT)a Cinacalcet (%)28 (31.11)19 (27.94)9 (40.91)0.253 Calcitriol (%)27 (30.00)20 (29.14)7 (31.82)0.830 Calcium-containing phosphate binders (%)61 (67.78)46 (67.65)15 (68.18)0.963 Non-calcium-containing phosphate binders (%)42 (46.67)31 (45.59)11 (50.00)0.718 AAC score54.00 (18.00, 119.00)32.00 (10.50, 75.00)154.00 (131.75, 179.75) < 0.001 vBMD, mg/cm3104.22 ± 39.44111.82 ± 38.6680.73 ± 32.500.001vBMD stratification Normal (%)32 (35.56)29 (42.65)3 (13.64)0.020 Osteopenia (%)31 (34.44)24 (35.29)7 (31.82)0.490 Osteoporosis (%)27 (30)15 (22.06)12 (54.54)0.007Corrected calcium, mmol/L2.23 ± 0.172.22 ± 0.172.26 ± 0.160.304Phosphate, mmol/L1.76 ± 0.501.7 ± 0.471.96 ± 0.530.032iPTH, pg/ml201 (127.6, 319.68)178 (116.05, 306.38)243.9 (163.75, 500.3)0.086Hemoglobin, g/L117.42 ± 9.98116.71 ± 9.49119.64 ± 11.320.233Albumin, g/L39.36 ± 2.4539.37 ± 2.3039.35 ± 2.910.969TG, mmol/L1.96 ± 1.271.90 ± 1.322.13 ± 1.110.459TC, mmol/L3.73 ± 0.843.67 ± 0.813.91 ± 0.910.253LDL-C, mmol/L1.94 ± 0.671.90 ± 0.682.06 ± 0.650.343CO2CP, %49.93 ± 5.8349.75 ± 5.6950.50 ± 6.330.603ALP, IU/L64 (54, 78)64 (55, 77.50)64.50 (50.75, 90.25)0.749Kt/V1.40 ± 0.281.36 ± 0.281.51 ± 0.240.034hsCRP, mg/L2.02 (0.89, 5.95)1.80 (0.80, 5.43)3.70 (0.98, 12.65)0.197Ferritin, ng/ml265.87 (222.56, 358.52)250.01 (200.41, 329.16)325.50 (249.57, 468.83)0.01625-(OH)-D3, ng/ml16.10 ± 7.1015.65 ± 6.5717.50 ± 8.530.292The bold data represent P values are less than 0.05Abbreviations: BMI body mass index, AAC score abdominal aortic calcification score, DKD diabetic kidney disease, CG chronic glomerulonephritis, HRD hypertensive renal damage, vBMD volumetric bone mineral density, iPTH intact parathyroid hormone, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, CO2CP carbon dioxide combining power, ALP alkaline phosphatase, hsCRP high-sensitivity C-reactive protein, 25-(OH)-D3 25-hydroxycholecalciferolaOnly the medications in the table were included in this study.

Source: Clinical and biochemical characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The excluded patients were older (P = 0.033) and had lower albumin (P = 0.004) than the included patients because most patients who could not cooperate with QCT examination were old and seriously ill.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Relationship of abdominal aortic calcification with lumbar vertebral volumetric bone mineral density assessed by quantitative computed tomography in maintenance hemodialysis patients

Study design awaiting verification · Archives of Osteoporosis · 2022

Original publication title

Relationship of abdominal aortic calcification with lumbar vertebral volumetric bone mineral density assessed by quantitative computed tomography in maintenance hemodialysis patients

Tian-Yi Chen; Jie Yang; Li Zuo; Ling Wang; Li-Fang Wang

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

There was an independent inverse association between AAC and vBMD, and osteoporosis was significantly associated with severe AAC in patients with MHD.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

This cross-sectional study aimed to investigate the relationship between abdominal aortic calcification (AAC), which is a marker of vascular calcification, and volumetric bone mineral density (vBMD) by quantitative computed tomography (QCT) in maintenance hemodialysis (MHD) patients.

Source: Introduction

Abstract: What methods does the paper describe?

All participants underwent lumbar vertebral vBMD measurement by QCT. Eight cross-sections were extracted sequentially and analyzed by ImageJ software to obtain the ratio of the calcified area to the abdominal aortic area (the calcification ratio). The AAC score was determined by the sum of the calcification ratios. The relationship between AAC and vBMD was analyzed using multivariate logistic regression.

Source: Methods

Abstract: Results

Ninety MHD patients (58.89% male) with a mean age of 63.43 (standard deviation [SD] = 13.20) years were included in the study. AAC was present (AAC score > 0) in 93.33% of the patients. The 75th percentile of the AAC score corresponding to 119 was used as the cutoff point between the mild and severe groups. After full adjustment in the logistic model, AAC was found to be inversely associated with vBMD (odds ratio [OR], 0.970; 95% confidence interval [CI], 0.944 to 0.996; P = 0.025), and patients with osteoporosis had a significantly higher risk of severe AAC than those with normal bone mass (OR, 14.498; 95% CI, 1.507 to 139.486; P = 0.021).

The independent inverse association was still stable after adjusting for variables measured at different time periods and using different cutoff points of the AAC score.

Source: Results

Abstract: Conclusion

There was an independent inverse association between AAC and vBMD, and osteoporosis was significantly associated with severe AAC in patients with MHD.

Source: Conclusion
Authors’ abstract

Introduction

This cross-sectional study aimed to investigate the relationship between abdominal aortic calcification (AAC), which is a marker of vascular calcification, and volumetric bone mineral density (vBMD) by quantitative computed tomography (QCT) in maintenance hemodialysis (MHD) patients.

Methods

All participants underwent lumbar vertebral vBMD measurement by QCT. Eight cross-sections were extracted sequentially and analyzed by ImageJ software to obtain the ratio of the calcified area to the abdominal aortic area (the calcification ratio). The AAC score was determined by the sum of the calcification ratios. The relationship between AAC and vBMD was analyzed using multivariate logistic regression.

Results

Ninety MHD patients (58.89% male) with a mean age of 63.43 (standard deviation [SD] = 13.20) years were included in the study. AAC was present (AAC score > 0) in 93.33% of the patients. The 75th percentile of the AAC score corresponding to 119 was used as the cutoff point between the mild and severe groups. After full adjustment in the logistic model, AAC was found to be inversely associated with vBMD (odds ratio [OR], 0.970; 95% confidence interval [CI], 0.944 to 0.996; P = 0.025), and patients with osteoporosis had a significantly higher risk of severe AAC than those with normal bone mass (OR, 14.498; 95% CI, 1.507 to 139.486; P = 0.021).

The independent inverse association was still stable after adjusting for variables measured at different time periods and using different cutoff points of the AAC score.

Conclusion

There was an independent inverse association between AAC and vBMD, and osteoporosis was significantly associated with severe AAC in patients with MHD.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11657-022-01059-z.

Publication and source details

Original title: Relationship of abdominal aortic calcification with lumbar vertebral volumetric bone mineral density assessed by quantitative computed tomography in maintenance hemodialysis patients

Tian-Yi Chen; Jie Yang; Li Zuo; Ling Wang; Li-Fang Wang

Archives of Osteoporosis · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.beijing jishuitan hospital foundation for young scholarsQN-201922Chen Tian-Yi

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T10:19:09.854826+00:00

DOI: 10.1007/s11657-022-01059-z · PMC8791896